Paying users zone. Data is covered by hidden.

  • Get 1 month access to Gilead Sciences Inc. for $17.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Gilead Sciences Inc. (GILD)


Long-term (Investment) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Gilead Sciences Inc., long-term (investment) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net fixed asset turnover hidden hidden hidden hidden hidden
Total asset turnover hidden hidden hidden hidden hidden
Equity turnover hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Gilead Sciences Inc.’s net fixed asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Gilead Sciences Inc.’s total asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Gilead Sciences Inc.’s equity turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Net Fixed Asset Turnover

Gilead Sciences Inc., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Product sales hidden hidden hidden hidden hidden
Property, plant and equipment, net hidden hidden hidden hidden hidden
Ratio
Net fixed asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Net fixed asset turnover = Product sales ÷ Property, plant and equipment, net
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Gilead Sciences Inc.’s net fixed asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Total Asset Turnover

Gilead Sciences Inc., total asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Product sales hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
Total asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Total Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Total asset turnover = Product sales ÷ Total assets
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Gilead Sciences Inc.’s total asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Equity Turnover

Gilead Sciences Inc., equity turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Product sales hidden hidden hidden hidden hidden
Total Gilead stockholders’ equity hidden hidden hidden hidden hidden
Ratio
Equity turnover1 hidden hidden hidden hidden hidden
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Equity Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Equity Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Equity turnover = Product sales ÷ Total Gilead stockholders’ equity
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Gilead Sciences Inc.’s equity turnover deteriorated from 2016 to 2017 and from 2017 to 2018.